Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's (SZSE:000766) Market Cap Rose CN¥532m Last Week; Retail Investors Who Hold 58% Profited and so Did Insiders

Simply Wall StDec 3 22:39 ET

tonghua golden-horse pharmaceutical industry co,ltd (000766.SZ): Subsidiaries are expected to invest no more than 0.1 billion yuan to build an artificial musk breeding base

On November 27, Ge Long Hui reported that tonghua golden-horse pharmaceutical industry co,ltd (000766.SZ) announced that based on future development global strategy and business development needs, to further enhance the comprehensive competitiveness of Yongkang Pharmaceutical, it agreed to implement the construction of an artificial musk breeding base focused on musk as the core fulcrum, with an expected investment amount not exceeding 100 million yuan. The project plans to complete the construction of the pens and supporting facilities, equipment procurement, and introduction of breeding stock by the end of June 2025. Through this base construction project, the scale of deer breeding will be expanded, extending the musk industry chain to achieve 'deer breeding, raw material extraction,'

Gelonghui FinanceNov 27 04:33 ET

Tonghua Golden-Horse Pharmaceutical's Q3 Profit Surges 140%

MT NewswiresOct 22 01:50 ET

Tonghua Jinma: Report for the third quarter of 2024

SZSIOct 20 12:00 ET · Announcements

tonghua golden-horse pharmaceutical industry co,ltd (000766.SZ): Amber Octahydroamino-adamantane Tablets obtained PCT patent protection in 15 countries.

Gelonghui October 15th | Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ) announced that Amber Octahydroamino Atdipine tablets are a new, potent, and clearly defined acetylcholinesterase inhibitor, a class 1 new drug with completely independent intellectual property rights and a new chemical molecular structure, used for the treatment of mild to moderate Alzheimer's disease. At the same time, the main crystal form of Amber Octahydroamino Atdipine has successively obtained international PCT (Patent Cooperation Treaty) patent protection, with the Japanese patent authorized in September 2022 and the European patent authorized in May 2023. The specific countries include the following 15 countries: United Kingdom, Germany, Swiss Franc, Sweden, Netherlands, Denmark.

Gelonghui FinanceOct 15 04:57 ET

Here's Why Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) Has Caught The Eye Of Investors

Simply Wall StAug 21 18:20 ET